| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $45.0M | $27.5M | $41.3M |
| YoY Revenue Growth % | +63.4% | -33.3% | — |
| Gross Profit | $19.5M | $9.5M | — |
| Gross Margin % | 43.4% | 34.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$25.2M | -$34.4M | -$25.4M |
| Operating Margin % | -56.1% | -80.0% | -61.5% |
| Net Income (GAAP) | -$40.1M | -$48.8M | -$31.3M |
| EBITDA (Normalized) | -$25.2M | -$34.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.4M | -$30.6M | -$16.1M |
| Capital Expenditures (CapEx) | $77.1K | $5.1K | — |
| Free Cash Flow (FCF) | -$18.5M | -$30.6M | -$16.1M |
| FCF Margin % | -41.1% | -80.0% | -38.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $35.7M | $12.0M | — |